347 related articles for article (PubMed ID: 34305927)
1. Allergic Aspects of IgG4-Related Disease: Implications for Pathogenesis and Therapy.
Michailidou D; Schwartz DM; Mustelin T; Hughes GC
Front Immunol; 2021; 12():693192. PubMed ID: 34305927
[TBL] [Abstract][Full Text] [Related]
2. The Cellular and Molecular Bases of Allergy, Inflammation and Tissue Fibrosis in Patients with IgG4-related Disease.
Hsieh SC; Shen CY; Liao HT; Chen MH; Wu CH; Li KJ; Lu CS; Kuo YM; Tsai HC; Tsai CY; Yu CL
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708432
[TBL] [Abstract][Full Text] [Related]
3. Immune Dysregulation in IgG
Liu J; Yin W; Westerberg LS; Lee P; Gong Q; Chen Y; Dong L; Liu C
Front Immunol; 2021; 12():738540. PubMed ID: 34539675
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G4-Related Disease: What an Allergist Should Know.
Carballo I; González-Quintela A; Sopeña B; Vidal C
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):212-227. PubMed ID: 32732179
[TBL] [Abstract][Full Text] [Related]
5.
Zongfei J; Rongyi C; Xiaomeng C; Lili M; Lingying M; Xiufang K; Xiaomin D; Zhuojun Z; Huiyong C; Ying S; Lindi J
Front Immunol; 2020; 11():1272. PubMed ID: 32733444
[No Abstract] [Full Text] [Related]
6. IgG4-related disease: How to place it in the spectrum of immune-mediated and rheumatologic disorders?
Borges T; Silva S
Mod Rheumatol; 2020 Jul; 30(4):609-616. PubMed ID: 31852351
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease.
Della Torre E; Mattoo H; Mahajan VS; Carruthers M; Pillai S; Stone JH
Allergy; 2014 Feb; 69(2):269-272. PubMed ID: 24266692
[TBL] [Abstract][Full Text] [Related]
8. [The similar characteristics of IgG4-related disease and allergic diseases].
Bian SN; Guan K
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Dec; 57(12):1936-1941. PubMed ID: 38186139
[TBL] [Abstract][Full Text] [Related]
9. Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease.
Culver EL; Sadler R; Bateman AC; Makuch M; Cargill T; Ferry B; Aalberse R; Barnes E; Rispens T
Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1444-1452.e6. PubMed ID: 28223204
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G4: an odd antibody.
Aalberse RC; Stapel SO; Schuurman J; Rispens T
Clin Exp Allergy; 2009 Apr; 39(4):469-77. PubMed ID: 19222496
[TBL] [Abstract][Full Text] [Related]
11. High-throughput RNA sequencing reveals distinct gene signatures in active IgG4-related disease.
Higgs BW; Liu Y; Guo J; Sebastian Y; Morehouse C; Zhu W; Ren L; Liu M; Du Y; Yu G; Dong L; Hua H; Wei P; Wang Y; Wang Z; Yao Y; Li ZG
Sci Rep; 2017 Dec; 7(1):17567. PubMed ID: 29242501
[TBL] [Abstract][Full Text] [Related]
12. New insights into the pathophysiology of IgG4-related disease and markers of disease activity.
Yamada K; Mizushima I; Kawano M
Expert Rev Clin Immunol; 2019 Mar; 15(3):231-239. PubMed ID: 30557078
[TBL] [Abstract][Full Text] [Related]
13. Cytokines produced by innate immune cells in IgG4-related disease.
Yoshikawa T; Watanabe T; Minaga K; Kamata K; Kudo M
Mod Rheumatol; 2019 Mar; 29(2):219-225. PubMed ID: 30334477
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease.
Minaga K; Watanabe T; Hara A; Yoshikawa T; Kamata K; Kudo M
Front Immunol; 2021; 12():713779. PubMed ID: 34367181
[TBL] [Abstract][Full Text] [Related]
15. Significance of high serum IgG4 in complete or non-full-fledged IgG4-related disease-a retrospective investigation of 845 patients and its clinical relevance.
Tsai HC; Tung HY; Liu CW; Su CF; Sun YS; Chen WS; Chen MH; Lai CC; Liao HT; Yang YY; Huang YH; Tsai CY
Clin Rheumatol; 2022 Jan; 41(1):115-122. PubMed ID: 34455508
[TBL] [Abstract][Full Text] [Related]
16. Multiple Processes May Involve in the IgG4-RD Pathogenesis: An Integrative Study via Proteomic and Transcriptomic Analysis.
Cai S; Chen Y; Lin S; Ye C; Zheng F; Dong L
Front Immunol; 2020; 11():1795. PubMed ID: 32973752
[TBL] [Abstract][Full Text] [Related]
17. IgG4-related disease: an update on pathophysiology and implications for clinical care.
Perugino CA; Stone JH
Nat Rev Rheumatol; 2020 Dec; 16(12):702-714. PubMed ID: 32939060
[TBL] [Abstract][Full Text] [Related]
18. Activated M2 Macrophages Contribute to the Pathogenesis of IgG4-Related Disease via Toll-like Receptor 7/Interleukin-33 Signaling.
Ishiguro N; Moriyama M; Furusho K; Furukawa S; Shibata T; Murakami Y; Chinju A; Haque ASMR; Gion Y; Ohta M; Maehara T; Tanaka A; Yamauchi M; Sakamoto M; Mochizuki K; Ono Y; Hayashida JN; Sato Y; Kiyoshima T; Yamamoto H; Miyake K; Nakamura S
Arthritis Rheumatol; 2020 Jan; 72(1):166-178. PubMed ID: 31339007
[TBL] [Abstract][Full Text] [Related]
19. The front line of research into immunoglobin G4-related disease - Do autoantibodies cause immunoglobin G4-related disease?
Umehara H; Okazaki K; Kawano M; Tanaka Y
Mod Rheumatol; 2019 Mar; 29(2):214-218. PubMed ID: 30557067
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 contributes to the shift of balance of IgG subclasses toward IgG4 in IgG4-related disease.
Akiyama M; Yasuoka H; Yoshimoto K; Takeuchi T
Cytokine; 2018 Oct; 110():416-419. PubMed ID: 29861381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
